Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 5mg/5ml		Solution	278,175 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 10mg	10mg	Tablet, film coated	593,978 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 1%	1%	Drops	170,668 L.L
J01DC02	ZILISTEN	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	155,886 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	908,603 L.L
J01DC02	ZINOXIMOR	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	698,798 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg/5ml	250mg/5ml	Granules for suspension	1,120,782 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg	250mg	Tablet, film coated	349,399 L.L
J01DI54	ZERBAXA	B	Ceftolozane Sulfate - 1g, Tazobactam (sodium) - 0.5g		Injectable powder for concentrate for solution	74,780,802 L.L
J01DI01	ZEVTERA	B	Ceftobiprole medocaril Sodium - 500mg	500mg	Injectable powder for concentrate for solution	47,129,773 L.L
J01DD52	ZAVICEFTA	B	Ceftazidime - 2g, Avibactam - 0.5g		Injectable powder for concentrate for solution	101,659,975 L.L
J01DI02	ZINFORO	G	Ceftaroline fosamil - 600mg	600mg	Injectable powder for concentrate for solution	44,995,862 L.L
J01DD13	ZAKON	G	Cefpodoxime (proxetil) - 100mg/5ml	100mg/5ml	Powder for suspension	1,116,733 L.L
C07AB07	ZIOPROL	G	Bisoprolol - 5mg	5mg	Tablet, film coated	409,552 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,965,229 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	14,800,115 L.L
J01FA10	ZITHROFORTE	G	Azithromycin (dihydrate) - 500mg	500mg	Tablet, film coated	485,127 L.L
J01FA10	ZITHROMAX	B	Azithromycin (dihydrate) - 300mg/7.5ml	300mg/7.5ml	Powder for suspension	489,159 L.L
J01FA10	ZITHROMAX	B	Azithromycin (dihydrate) - 250mg	250mg	Capsule	591,291 L.L
J01FA10	ZETRON	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01FA10	ZEVLEN	G	Azithromycin (dihydrate) - 250mg	250mg	Tablet, film coated	409,552 L.L
J01FA10	ZIMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	258,018 L.L
L01BC07	ZYDROME	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	10,967,854 L.L
N05AX12	ZALONIL	G	Aripiprazole - 15mg	15mg	Tablet, orodispersible	2,426,980 L.L
N05AX12	ZALONIL	G	Aripiprazole - 10mg	10mg	Tablet, orodispersible	1,988,887 L.L
L02BG03	ZORTEX	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,944,092 L.L
M04AA01	ZYLORIC	B	Allopurinol - 300mg	300mg	Tablet	302,365 L.L
M04AA01	ZYLORIC	B	Allopurinol - 100mg	100mg	Tablet	278,175 L.L